Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory Study Assessing the Efficacy and Safety of Semaglutide for Idiopathic Intracranial Hypertension Treatment

NCT06361823 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.

NCT NCT06361823
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06361823 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory Study Assessing the Efficacy and Safety of Semaglutide for Idiopathic Intracranial Hypertension Treatment
Lead sponsor
Capital Medical University
Phase
Phase 3
Overall status
Unknown status
Start date
May 1, 2024
Completion date
January 1, 2025
Enrollment
74 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic intracranial hypertension